The COVID-19 pandemic: a systematic review of the current evidence

Cover Page


Cite item

Full Text

Abstract

Introduction. An epidemic of Coronavirus Disease 2019 (COVID-19) begun in December 2019 in China, causing primary concern. One of the important issues is its rapid spread around the world. Among the questions raised, disease epidemiology, clinical, laboratory symptoms and radiological findings and treatment of COVID-19 disease have been identified in some studies. But no systematic review on current evidences about COVID-19 has been published.

Objective. The aim of this study was to determine the COVID-19 epidemiology, clinical features, diagnosis and treatment.

Data sources. We performed a systematic review of the literature, using the keywords: “coronavirus” and “2020”, “COVID-19” in databases: Science Direct, PubMed, Springer and Scopus during January 1, 2020 to February 23, 2020.

Study Selection. All observational studies, as well as case reports and editorial that published in English were include. Data Extraction. Data on the disease control methods of COVID-19 were extracted by multiple observers.

Results. 131 articles were retrieved. After screening by abstract and title, 58 articles were selected for full-text assessment. Of them, 43 were finally included for review. The COVID-19 has spread rapidly and can be transmitted via close human-to-human contact via nasopharyngeal or oropharyngeal droplets. The COVID-19, causing considerable problems, especially in patients with comorbidities and old patients. Fever, cough, sore throat and diarrhea are the main clinical features of this emerging disease. The most common radiological finding is bilateral ground-glass view and Lopinavir and Ritonavir are among the antiviral drugs used.

Conclusion. COVID-19 is a new clinical infectious disease and can be a serious problem for health systems. Additional research is needed to elucidate factors that may mediate the pathogenesis of the severe and fatal associated disease.

About the authors

R. Ghomi

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Email: razbebehzadmehr@gmail.com
Iran, Islamic Republic of

N. Asgari

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Author for correspondence.
Email: razbebehzadmehr@gmail.com

Narges Asgari

Iran, Islamic Republic of

A. Hajiheydari

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Email: razbebehzadmehr@gmail.com
Iran, Islamic Republic of

R. Esteki

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Email: razbebehzadmehr@gmail.com
Iran, Islamic Republic of

F. Biyabanaki

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Email: razbebehzadmehr@gmail.com
Iran, Islamic Republic of

F. Nasirinasab

9 Dey Manzariyeh Hospital, Isfahan University of medical science

Email: razbebehzadmehr@gmail.com
Iran, Islamic Republic of

References

  1. Al-Tawfiq J.A., Zumla A., Memish Z.A. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med. Infect. Dis., 2014, vol. 12, no. 5, pp. 422—428. doi: 10.1016/j.tmaid.2014.06.007
  2. Albarello F., Pianura E., Di Stefano F., Cristofaro M., Petrone A., Marchioni L., Palazzolo C., Schinina V., Nicastri E., Petrosillo N., Campioni P., Eskild P., Zumla A., Ippolito G.; COVID 19 INMI Study Group. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation. Int. J. Infect. Dis., 2020, vol. 93, pp. 192-197. doi: 10.1016/j.ijid.2020.02.043
  3. Arabi Y.M., Alothman A., Balkhy H.H., Al-Dawood A., Al Johani S., Al Harbi S., Kojan S., Al Jeraisy M., Deeb A.M., Assiri A.M., Al-Hameed F., Al Saedi A., Mandourah Y., Almekhlafi G.A., Sherbeeni N.M., Elzein F.E., Memon J., Taha Y., Almotairi A., Maghrabi K.A., Qushmaq I., Al Bshabshe A., Kharaba A., Shalhoub S., Jose J., Fowler R.A., Hayden F.G., Hussein M.A.; The MIRACLE trial group. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-в 1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials, 2018, vol. 19, no. 1: 81. doi: 10.1186/s13063-017-2427- 0
  4. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., Flemban H., Al-Nassir W.N., Balkhy H.H., Al-Hakeem R.F., Makhdoom H.Q., Zumla A.I., Memish Z.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis,, 2013, vol. 13, no. 9, pp. 752-61. doi: 10.1016/S1473-3099(13)70204-4
  5. Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA, 2020, vol. 323, no. 14, pp. 1406-1407. doi: 10.1001/jama.2020.2565
  6. Bonilla-Aldana D.K., Quintero-Rada K., Montoya-Posada J.P., Ramfrez-Ocampo S., Paniz-Mondolfi A., Rabaan A.A., Sah R., Rodrfguez-Morales A.J. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronavi-ruses? A bibliometric analysis. Travel Med. Infect. Dis., 2020, vol. 33:101566. doi: 10.1016/j.tmaid.2020.101566
  7. Centers for Disease Control and Prevention C. 2019 Novel Coronavirus (2019-nCoV). 2020. URL: https://www.cdc.gov/coronavirus/2019-ncov/index.html
  8. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., Tsoi H.W., Lo S.K., Chan K.H., Poon V.K., Chan W.M., Ip J.D., Cai J.P., Cheng V.C., Chen H., Hui C.K., Yuen K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, vol. 395, no. 10223, pp. 514-523. doi: 10.1016/S0140-6736(20)30154-9
  9. Chan-Yeung M., Xu R.H. SARS: epidemiology. Respirology, 2003, vol. 8 (suppl. 1), pp. S9-S14. doi: 10.1046/j.1440-1843.2003.00518.x. PMID: 15018127; PMCID: PMC7169193.
  10. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet, 2020, vol. 395, pp. 809-815. doi: 10.1016/j.jemermed.2020.04.003
  11. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, vol. 395, no. 10223, pp. 507-513. doi: 10.1016/S0140-6736(20)30211-7
  12. Chen Q., Liang M., Li Y., Guo J., Fei D., Wang L., He L., Sheng C., Cai Y., Li X., Wang J., Zhang Z. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4, pp. e15-e16. doi: 10.1016/S2215-0366(20)30078-X
  13. Chen X., Tian J., Li G., Li G. Initiation of a new infection control system for the COVID-19 outbreak. Lancet Infect Dis., 2020, vol. 20, no. 4, pp. 397-398. doi: 10.1016/S1473-3099(20)30110-9
  14. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol., 2020, vol. 92, no. 4, pp. 418-423. doi: 10.1002/jmv.25681
  15. Cheng Z.J., Shan J. 2019 Novel coronavirus: where we are and what we know. Infection., 2020, vol. 48, no. 2, pp. 155-163. doi: 10.1007/s15010-020-01401-y
  16. Chu C.M., Cheng V.C., Hung I.F., Wong M.M., Chan K.H., Chan K.S., Kao R.Y., Poon L.L., Wong C.L., Guan Y., Peiris J.S., Yuen K.Y.; HKU/UCH SARS Study Group. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 2004, vol. 59, no. 3, pp. 252-256. doi: 10.1136/thorax.2003.012658
  17. Cohen E.C. CDC to screen at three US airports for signs of new virus from China. CNN Health. 2020. January 17. URL: https://edition.cnn.com/2020/01/17/health/wuhan-virus-us-airport-screenings-china-bn/index.html
  18. COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020). Commun. Dis. Intell. (2018), 2020: 44. doi: 10.33321/cdi.2020.44.14
  19. COVID-19: fighting panic with information. Lancet, 2020, vol. 395, no. 10224, p. 537. doi: 10.1016/S0140-6736(20)30379-2
  20. De Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z.A., Perlman S., Poon L.L., Snijder E.J., Stephens G.M., Woo P.C., Zaki A.M., Zambon M., Ziebuhr J. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol., 2013, vol. 87, no. 14, pp. 7790-7792. doi: 10.1128/JVI.01244-13
  21. De Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016, vol. 14, no. 8, pp. 523-534. doi: 10.1038/nrmicro.2016.81
  22. Gao J., Tian Z., Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends, 2020, vol. 14, no. 1, pp. 72-73. doi: 10.5582/bst.2020.01047
  23. Gardner L. Mapping COVID-19. 2020. URL: https://systems.jhu.edu/research/public-health/ncov
  24. Gostic K., Gomez A.C., Mummah R.O., Kucharski A.J., Lloyd-Smith J.O. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife, 2020, vol. 9: e55570. doi: 10.7554/eLife.55570
  25. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., Du B., Li L., Zeng G., Yuen K.-Y., Chen R., Tang C., Wang T., Chen P., Xiang J., Li S., Wang J., Liang Z., Peng Y., Wei L., Liu Y., Hu Y., Peng P., Wang J., Liu J., Chen Z., Li G., Zheng Z., Qiu S., Luo J., Ye C., Zhu S., Zhong N., for the China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020, vol. 382, pp. 1708-1720. doi: 10.1056/NEJMoa2002032
  26. Guarner J. Three emerging coronaviruses in two decades. Am. J. Clin. Pathol., 2020, vol. 153, no. 4, pp. 420-421. doi: 10.1093/ajcp/aqaa029
  27. Habibzadeh P., Stoneman E.K. The Novel Coronavirus: a bird’s eye view. Int. J. Occup. Environ. Med., 2020, vol. 11, no. 2, pp. 6571. doi: 10.15171/ijoem.2020.1921
  28. Hernandez J.C., Austin Ramzy T. China confirms new coronavirus spreads from humans to humans. The New York Times. 2020. 24 January. URL: https://www.nytimes.com/2020/01/20/world/asia/coronavirus-china-symptoms.html
  29. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, vol. 395, no. 10223, pp. 497-506. doi: 10.1016/S0140-6736(20)30183-5
  30. Jalava K. First respiratory transmitted food borne outbreak? Int. J. Hyg. Environ. Health, 2020, vol. 226: 113490. doi: 10.1016/j.ijheh.2020.113490
  31. Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? Eur. Radiol., 2020, vol. 30, pp. 3266-3267. doi: 10.1007/s00330-020-06748-2
  32. Kim J.Y., Ko J.H., Kim Y., Kim Y.J., Kim J.M., Chung Y.S., Kim H.M., Han M.G., Kim S.Y., Chin B.S. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J. Korean Med. Sci., 2020, vol. 35, no. 7: e86. doi: 10.3346/jkms.2020.35.e86
  33. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coro-navirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents, 2020, vol. 55, no. 3: 105924. doi: 10.1016/j.ijantimicag.2020.105924
  34. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., Sung J.J. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med., 2003, vol. 348, no. 20, pp. 1986-1994. doi: 10.1056/NEJMoa030685
  35. Liem A., Wang C., Wariyanti Y., Latkin C.A., Hall B.J. The neglected health of international migrant workers in the COVID-19 epidemic. Lancet Psychiatry, 2020, vol. 7, no. 4: e20. doi: 10.1016/S2215-0366(20)30076-6
  36. Lim J., Jeon S., Shin H.Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.W., Kang Y.M., Lee B., Park S.J. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of Lopinavir/Ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Korean. Med. Sci., 2020, vol. 35, no. 6: e79. doi: 10.3346/jkms.2020.35.e79
  37. Lin C., Ding Y., Xie B., Sun Z., Li X., Chen Z., Niu M. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease. Clin. Imaging, 2020, vol. 63, pp. 7-9. doi: 10.1016/j.clinimag.2020.02.008
  38. Lin X., Gong Z., Xiao Z., Xiong J., Fan B., Liu J. Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean J. Radiol., 2020, vol. 21, no. 3, pp. 365-368. doi: 10.3348/kjr.2020.0078
  39. Liu S., Yang L., Zhang C., Xiang Y.T., Liu Z., Hu S., Zhang B. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4, pp. e17-e18. doi: 10.1016/S2215-0366(20)30077-8
  40. Lum L.H.W., Tambyah P.A. Outbreak of COVID-19 — an urgent need for good science to silence our fears? Singapore Med. J., 2020, vol. 61, no. 2, pp. 55-57. doi: 10.11622/smedj.2020018
  41. MacLaren G., Fisher D., Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA, 2020, vol. 323, no. 13, pp. 1245-1246. doi: 10.1001/jama.2020.2342
  42. Moher D., Liberati A., Tetzlaff J., Altman D.G.; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med., 2009, vol. 6, no. 7: e1000097. doi: 10.1371/journal.pmed.1000097
  43. Nassar M.S., Bakhrebah M.A., Meo S.A., Alsuabeyl M.S., Zaher W.A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. Eur. Rev. Med. Pharmacol, Sci., 2018, vol. 22, no. 15, pp. 4956-4961. doi: 10.26355/eurrev_201808_15635
  44. Pan Y., Guan H. Imaging changes in patients with 2019-nCov. Eur. Radiol., 2020, vol. 30, no. 7, pp. 3612-3613. doi: 10.1007/s00330-020-06713-z
  45. Peeri N.C., Shrestha N., Rahman M.S., Zaki R., Tan Z., Bibi S., Baghbanzadeh M., Aghamohammadi N., Zhang W., Haque U. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int. J. Epidemiol., 2020, vol. 49, no. 3, pp. 717-726. doi: 10.1093/ije/dyaa033
  46. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet, 2020, vol. 395, no. 10226,pp. 760-762. doi: 10.1016/S0140-6736(20)30365-2
  47. Qin C., Liu F., Yen T.C., Lan X. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. Eur. J. Nucl. Med. Mol. Imaging, 2020, vol. 47, no. 5, pp. 1281-1286. doi: 10.1007/s00259-020-04734-w
  48. Rivers C.M., Majumder M.S., Lofgren E.T. Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012—2015. Am. J. Epidemiol, 2016, vol. 184, no. 6, pp. 460-464. doi: 10.1093/aje/kww013
  49. Sabino-Silva R., Jardim A.C.G., Siqueira W.L. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin. OralInvestig., 2020, vol. 24, no. 4, pp. 1619-1621. doi: 10.1007/s00784-020-03248-x
  50. Sheahan T.P., Sims A.C., Graham R.L., Menachery V.D., Gralinski L.E., Case J.B., Leist S.R., Pyrc K., Feng J.Y., Trantcheva I., Bannister R., Park Y., Babusis D., Clarke M.O., Mackman R.L., Spahn J.E., Palmiotti C.A., Siegel D., Ray A.S., Cihlar T., Jordan R., Denison M.R., Baric R.S. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med., 2017, vol. 9, no. 396: eaal3653. doi: 10.1126/scitranslmed.aal3653
  51. Sheahan T.P., Sims A.C., Leist S.R., Schafer A., Won J., Brown A.J., Montgomery S.A., Hogg A., Babusis D., Clarke M.O., Spahn J.E., Bauer L., Sellers S., Porter D., Feng J.Y., Cihlar T., Jordan R., Denison M.R., Baric R.S. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun., 2020, vol. 11, no. 1,p. 222. doi: 10.1038/s41467-019-13940-6
  52. Song P., Karako T. COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern. Biosci. Trends, 2020, vol. 14, no. 1, pp. 1-2. doi: 10.5582/bst.2020.01056
  53. Srikantiah P., Charles M.D., Reagan S., Clark T.A., Pletz M.W., Patel P.R., Hoekstra R.M., Lingappa J., Jernigan J.A., Fischer M. SARS clinical features, United States, 2003. Emerg. Infect. Dis., 2005, vol. 11, no. 1, pp. 135-138. doi: 10.3201/eid1101.040585
  54. Tian S., Hu N., Lou J., Chen K., Kang X., Xiang Z., Chen H., Wang D., Liu N., Liu D., Chen G., Zhang Y., Li D., Li J., Lian H., Niu S., Zhang L., Zhang J. Characteristics of COVID-19 infection in Beijing. J. Infect., 2020, vol. 80, no. 4, pp. 401-406. doi: 10.1016/j.jinf2020.02.018
  55. Tong Z.D., Tang A., Li K.F., Li P., Wang H.L., Yi J.P., Zhang Y.L., Yan J.B. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020. Emerg. Infect. Dis, 2020, vol. 26, no. 5, pp. 1052-1054. doi: 10.3201/eid2605.200198
  56. Tsang K.W., Ho P.L., Ooi G.C., Yee W.K., Wang T., Chan-Yeung M., Lam W.K., Seto W.H., Yam L.Y., Cheung T.M., Wong P.C., Lam B., Ip M.S., Chan J., Yuen K.Y., Lai K.N. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med, 2003, vol. 348, no. 20, pp. 1977-85. doi: 10.1056/NEJMoa030666
  57. Van Cuong L., Giang H.T.N., Linh L.K., Shah J., Van Sy L., Hung T.H., Reda A., Truong L.N., Tien D.X., Huy N.T. The first Vietnamese case of COVID-19 acquired from China. Lancet Infect. Dis., 2020, vol. 20, no. 4, pp. 408-409. doi: 10.1016/S1473-3099(20)30111-0
  58. Velavan T.P., Meyer C.G. The C.O.V.ID-19 epidemic. Trop. Med. Int. Health, 2020, vol. 25, no. 3, pp. 278-280. doi: 10.1111/tmi.13383
  59. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet, 2020, vol. 395, no. 10223, pp. 470-473. doi: 10.1016/S0140-6736(20)30185-9
  60. Wong J.E.L., Leo Y.S., Tan C.C. COVID-19 in Singapore-current experience: critical global issues that require attention and action. JAMA,, 2020, vol. 323, no. 13, pp. 1243-1244. doi: 10.1001/jama.2020.2467
  61. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report-66. 2020. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=9e5b8b48_2
  62. Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., Zheng M., Chen L., Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B., 2020, vol. 10, no. 5, pp. 766-788. doi: 10.1016/j.apsb.2020.02.008
  63. Wu J., Wu X., Zeng W., Guo D., Fang Z., Chen L., Huang H., Li C. Chest CT findings in patients with Coronavirus Disease 2019 and its relationship with clinical features. Invest. Radiol., 2020, vol. 55, no. 5, pp. 257-261. doi: 10.1097/RLI.0000000000000670
  64. Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 2020, vol. 395, no. 10225, pp. 689-697. doi: 10.1016/S0140-6736(20)30260-9
  65. Xu Y.H., Dong J.H., An W.M., Lv X.Y., Yin X.P., Zhang J.Z., Dong L., Ma X., Zhang H.J., Gao B.L. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J. Infect., 2020, vol. 80, no. 4, pp. 394-400. doi: 10.1016/j.jinf2020.02.017
  66. Xu Z., Li S., Tian S., Li H., Kong L.Q. Full spectrum of COVID-19 severity still being depicted. Lancet., 2020, vol. 395, no. 10228, pp. 947-948. doi: 10.1016/S0140-6736(20)30308-1
  67. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T., Wang Y., Pan S., Zou X., Yuan S., Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med., 2020, vol. 8, no. 5, pp. 475-481. doi: 10.1016/S2213-2600(20)30079-5
  68. Yang Y., Li W., Zhang Q., Zhang L., Cheung T., Xiang Y.T. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, vol. 7, no. 4: e19. doi: 10.1016/S2215-0366(20)30079-1
  69. Yang Y., Shang W., Rao X. Facing the COVID-19 outbreak: what should we know and what could we do? J. Med. Virol., 2020, vol. 92, no. 6, pp. 536-537. doi: 10.1002/jmv.25720
  70. Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 2018, vol. 23, no. 2, pp. 130137. doi: 10.1111/resp.13196
  71. Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., Akdis C.A., Gao Y.D. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020, vol. 75, no. 7, pp. 1730-1741. doi: 10.1111/all.14238
  72. Zhang S., Diao M., Yu W., Pei L., Lin Z., Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. Int. J. Infect. Dis., 2020, vol. 93, pp. 201-204. doi: 10.1016/j.ijid.2020.02.033
  73. Zhang Y., Xu J., Li H., Cao B. A novel coronavirus (COVID-19) outbreak: a call for action. Chest, 2020, vol. 157, no. 4, pp. e99-e101. doi: 10.1016/j.chest.2020.02.014
  74. Zhu Y., Chen L., Ji H., Xi M., Fang Y., Li Y.. The risk and prevention of novel coronavirus pneumonia infections among inpatients in psychiatric hospitals. Neurosci. Bull., 2020, vol. 36, no. 3,pp. 299-302. doi: 10.1007/s12264-020-00476-9

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Ghomi R., Asgari N., Hajiheydari A., Esteki R., Biyabanaki F., Nasirinasab F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies